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Abstract
Minimally invasive liver resection (MILR) has evolved considerably in the past decade. Safe hepatic parenchymal
transection, has been one of the technical hurdles that has become evident during the growth of MILR. Advances in
technology have now made safe liver transection a reality allowing resections of greater magnitude. In this review, the
precoagulation approach is described in both methodology and technique. Using this method of liver transection, we have
been able to perform MILR of all varieties and magnitudes, with favorable patient outcomes. A detailed description of one
particular device will be highlighted to disseminate our experience and thus broaden the technical options for hepatobiliary
surgeons wishing to offer their patients a minimally invasive therapy.
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Introduction
Liver surgery has evolved considerably in the past
decade. Advances in surgical strategy and intraopera-
tive patient management, combined with focused
hepatobiliary experience and training, have made
technical feats possible, including: extended and ex
situ/ex vivo resections, complex vascular and biliary
reconstruction, and live-donor hepatectomy for liver
transplantation. While improved methods of parench-
ymal transection may have a factor in reduction of
patient morbidity and mortality, no one method has
been found to be superior in terms of patient outcome
[16].
More recently, minimally invasive liver resection
(MILR) has become a reality. It is now recognized
that MILR can be performed for both benign and
malignant conditions, for major resections, with
safety and outcomes comparable to the open ap-
proach [7]. In contrast to open surgery, MILR relies
heavily on the methods and devices for parenchymal
transection, given the inherent need for preemptive
and/or rapid hemostasis. This is particularly true for
MILR of large magnitudes (hemihepatectomy) where
large intrahepatic vessels are encountered. In this
scenario, reliable coagulation of parenchyma and
small vessels is paramount to a safe and precise
resection. Currently there are several devices de-
signed for precoagulation of the liver, using radio-
frequency-based technology. One such device is the
TissueLink Endo SH2.0TM Sealing Hook (SH) (Tis-
sueLink Medical Inc., Dover, NH). When used
correctly, the SH allows almost bloodless transection.
This method not only allows the hepatobiliary
surgeon to offer MILR to patients, but also makes
major hepatectomy a possibility in selected cases.
This review will focus on one method of liver
parenchymal transection during MILR. We will out-
line the device, methods of use, and review our
experience using this method for MILR to provide
surgeons with technical options when performing
minimally invasive hepatibiliary surgery.
Materials and methods
The following methods are based on recommended
device usage guidelines combined with our group’s
experience using this method in over 500 MILR. This
clinical experience includes over 150 hemihepatec-
tomies, and resection of livers varying in parenchymal
character.
ISSN 1365-182X print/ISSN 1477-2574 online # 2008 Informa UK Ltd.
DOI: 10.1080/13651820802166864
Correspondence: Alan Koffron, Department of Surgery, Memorial Hospital, Chicago, Illinois, 675 N. St. Clair Street, Galter Suite 17-200, Chicago, IL
60611, USA. Tel: 312-695-1769. Fax: 312-695-9194. E-mail: akoffron@nmh.org
HPB, 2008; 10: 225228
The TissueLink Endo SH2.0TM SH is designed to
pre-coagulate the liver parenchyma prior to transec-
tion (see Figure 1). Physically, the unit consists of an
elongated diathermy unit, married to a saline infusion
system. Ergonomically, the activation button is placed
so the surgeon can activate the device and simulta-
neously manipulate the distal hook during treatment.
This device centers on monopolar, saline-enhanced
radiofrequency (RF) technology to treat, seal, and
bluntly dissect liver tissue on a small scale for
progressive transection. As the tissue is gently heated,
this causes the tissue collagen to contract and
essentially ‘‘strangle’’ vascular structures and stroma
while simultaneously coagulating the hepatocyte/
sinusoid substance. Prior to the procedure, the device
is prepared by wire connection to a standard electro-
cautery unit (with patient grounding pad) and IV
tubing to a bag of 0.9 normal saline. In most instances
the electrocautery unit is set to 120 watts (coagula-
tion), and saline drip rate to 1 drop/second. Choreo-
graphy of the liver parenchymal transection includes:
scoring the liver capsule, superficial parenchymal
transection, deep dissection and transection, and
finally cut surface hemostasis.
Liver capsule
Once the liver is inspected with ultrasound, the
neoplasm of interest mapped, and the target lobe is
mobilized, the transection line is demarcated. The
saline is turned off temporarily rendering the device
similar to standard electrocautery. The line of trans-
ection is scored as in the open surgical approach.
Superficial parenchymal transection
Once the capsule is scored the superficial transection
is performed. Using the ‘‘heel’’ of the device (see
Figure 1) activate the device (button) with light,
constant pressure on the tissue combined with inter-
mittent pushing (aka ‘‘stomping’’) motions. The
desired effect is to have boiling of the saline, coagula-
tion of the tissue, and gentle blunt separation of the
treated region. The motion of the device and/or drip
rate made need to be titrated to achieve this effect.
With ample saline and motion, excessive steam, or the
opposite effect, electrical arcing, is avoided. None-
the-less it is important to have a suction apparatus
closely associated with the SH to scavenge steam (see
Figure 2). We prefer to use these two items in
combination: while the SH is activated the suction
apparatus is retracting the specimen side of the
transection plane, simultaneously scavenging steam.
As the device precoagulates the superficial parench-
yma, tactile feedback will indicate the presence either
stromal or small vascular structures. Because the
device (if activated and in constant contact with the
tissue) precoagulates the tissue several millimeters
deep to the actual divided liver, small vessels are being
treated and secured prior to their visualization. These
structures are then hooked with the ‘‘toe’’ of the
device (see Figure 1), further coagulated briefly, and
then divided by pulling the device, similar to the
action of the hook cautery during laparoscopic
cholecystectomy. Larger vessels are managed by
prolonging the coagulation step with a side-to-side
motion for added contraction and extended lateral
sealing prior to division. In the case where either the
parenchyma or small vessels are incompletely sealed
(hemorrhage), coagulating the site with a brief circu-
lar motion completes tissue contraction hemostasis in
almost all circumstances. Avoid over treating the
tissue as progressive collagen contraction will dimin-
ish tactile feedback and also inhibit retraction of the
transected liver diminishing exposure.
Deep dissection and transection
Naturally, as the transection proceeds deeper into the
liver substance, larger vessels will be encountered.
The technique is then altered to allow dissection of
those larger elements which require adjunctive devices
for sealing due to caliber. In our experience, the SH is
Figure 1. TissueLink Endo SH2.0TM Sealing Hook (SH). Note
similarity to laparoscopic hook cautery with added cable, IV tubing,
and activation button on handpiece. Inset: hook tip with ‘‘toe’’ and
‘‘heel’’. (Picture reproduced with permission from TissueLink
Medical).
Figure 2. Sealing Hook and suction during transection. Notice
close proximity of the SH and suction apparatus.
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able to seal up to 8mm vascular structures, but this is
dependent on treatment time, vessel nature (thick-
ness), and liver collagen content. While continuously
activated, the heel of the device is progressively
‘‘stomped’’ lightly on the tissue. This action gently
divides the intervening parenchyma, and allows de-
tection of oncoming vessels, which are then isolated
by dissecting the liver tissue above and below (see
Figure 3).
Once an intrahepatic vessel is identified and iso-
lated, it may be treated using the SH until visibly
coagulated, or, when appropriate, sealed and divided
using a coaptive device of choice. In the case where a
vessel is treated and breached, continued treatment, if
not sealing the vessel, will cause contraction and
therefore diminished hemorrhage (and theoretically
lessen the risk of gas embolus), promoting rapid
suture control of the site.
Cut surface hemostasis
Once transection is completed, the SH can be used to
achieve hemostasis on the cut surface using again a
circular motion. In our experience this provides
reliable hemostasis and removes the need for adjunc-
tive topical hemostatic agents or postoperative drai-
nage.
Special device nuances
Of special note is the mechanical behavior of the SH.
Since this device uses heat to function, logically the
surgeon must avoid causing bystander tissue damage.
The device should be used with caution near any
biliary structures, the diaphragm, or metal objects
which may cause conduction and arcing. Secondly,
steatotic livers, having a smaller proportion of tissue
collagen require prolonged treatment with the elec-
trocautery placed on a lower power setting (typically
90 Watts). In contrast, fibrotic/cirrhotic livers require
less device treatment but more meticulous dissection
as the tactile feedback is diminished by the inherent
tissue turgor. Lastly, swifter motions, in combination
with adequate saline flow, allow the device to coagu-
late most effectively, reduce tissue hardening, and
provide blunt separation of coagulated liver tissue
surrounding intrahepatic structures. These nuances in
the use of this device constitute what many surgeons
consider pitfalls early in their experience.
Results
Our center has performed over 500 MILR using the
SH, with acceptable patient outcomes. In our recent
report of 300 cases, we found, using the pre-coagula-
tion method of transection, an advantage of MILR
over open resection in terms of operating time, blood
loss, length of stay, and overall complications [7].
Furthermore, inflow occlusion was not necessary
using this approach, and no patient required reopera-
tion for hemorrhage. Biliary complications were
infrequent and no patient required surgical interven-
tion. Our subsequent cases have had similar clinical
results regardless of resection magnitude and the
incorporation of less experienced surgeons or trainees
into these procedures.
Discussion
Technological innovation and advancement are a
hallmark of contemporary surgical practice. More-
over, development of devices designed to divide solid
organs, have been pivotal in the transition to the
minimally invasive approach to liver surgery. During
the genesis of MILR, mobilization and vascular
dissection were perfected based largely on technical
experience gained in other clinical scenarios (gastro-
intestinal, renal, endocrine procedures). In contrast,
the laparoscopic division of the highly vascularized
liver was thought to be virtually insurmountable even
in the face of advances in open liver surgery.
As various devices were introduced and applied to
this unique surgical dilemma, we have seen a steady
clinical progression from the minimally invasive
treatment of liver cysts [8], to peripheral wedge
resections [9], major hepatectomy [7,10], and re-
cently donor hepatectomy [11,12]. Such a progres-
sion, in our opinion, is largely due to experience
combined with improvements in parenchymal trans-
ection technologies. Many centers embarking upon
MILR have seen a similar progression. In our center
we began with peripheral resections using coaptive
devices such as Harmonic Scalpel (Ethicon Endo-
Surgery, Cincinnati, OH) and LigaSure (ValleyLab,
Tyco Healthcare, Boulder, CO) with excellent results.
Later, preparing for hemihepatectomy, we and others
have utilized laparoscopic ultrasonic dissection
(CUSA, Tyco Healthcare, Mansfield, MA) with
improved ability to visualize intrahepatic vessels.
Endostaplers, while swift and able to transect
both parenchyma and vessels of any caliber, require
Figure 3. Sealing Hook isolating the intrahepatic left hepatic vein
(LHV). Note the smooth transection plane, exposure, and lack of
hemorrhage.
Laparoscopic liver surgery 227
adjunctive hemostatic devices and agents to achieve
hemostasis following liver division. With the advent of
devices designed for precoagulation of the liver tissue,
we and others have been able to perform the full
gamut of resection magnitudes [7,13], while dimin-
ishing surgical field device ‘‘traffic’’ during proce-
dures, without compromising clinical outcomes.
The SH, using the methods described above, is an
example of one such technological advancement. It
affords rapid transection of superficial hepatic par-
enchyma, without the need for inflow occlusion. More
importantly, deeper dissection of vascular structures is
possible, allowing their subsequent management with
a technique or device of choice. Our preferred method
is SH, followed by coaptive sealing device, and lastly
endostapling for inflow pedicles and proper heptic
veins. Cut surface hemostasis is achieved as the
transection proceeds, lending to shortened procedure
times, avoidance of adjuvant hemostatic agents and
surgical drains, reduced inpatient stays, and therefore
reduced operating costs [7].
While the SH is a simple device with logical
applications and usage, we have noticed several
phenomena which deserve discussion. First, the
device relies on ample saline to avoid charring and
arcing. When this occurs, the device becomes, in
essence, electrocautery, and therefore the surgeon
cannot take advantage of the precoagulation abilities
intended in the device’s design. Second, we have
noticed that surgeons unfamiliar with the SH tend to
overcoagulate the liver tissue. Logically, this should be
avoided as with any monopolar device, to reduce
bystander parenchymal or biliary necrosis. Further-
more, since heating the liver causes collagen contrac-
tion, over-treatment results in loss of cut surface
mobility and exposure, which is naturally deleterious
when attempting hemostatic technical maneuvers.
Surgeons inexperienced with the proper use of this
device may not appreciate the benefits of precoagula-
tion until the learning curve has been surpassed. In
our center, during educational procedures, the trainee
is reminded of the low risk of encountering large
vessels during superficial transection. This in turn
allows a more aggressive use of the device initially,
providing a sense familiarity and confidence, resulting
in less over-treatment of the tissue. Lastly, the
technique described enables the surgeon to identify
and localize intrahepatic vessels as tactile feedback
and experience progresses. It is our opinion that this is
a major advantage of this method. While the SH may
not be able to seal vessels of any caliber, gentle
treatment of vessels also causes contraction, and if
not completely sealed, the vessel is then more easily
managed by another approach or device.
In our group’s clinical series, the pre-coagulation
approach to liver transection affords safe management
of this pivotal step in MILR. Through this methodol-
ogy, resections of a variety of magnitudes can be
performed safely and efficiently, once the surgical
learning curve is passed. The SH is one device which,
when used properly, achieves the goals of deliberate
transection in combination with hemorrhage reduc-
tion. While no single device (as with open transection
methods) is best in all circumstances, familiarity,
experience, and surgeon comfort with such devices
will provide the best possible patient outcomes in
MILR. It is our hope that promotion and description
of these novel devices and their use will promote the
advancement of hepatobiliary surgery as the technol-
ogy and discipline continue to evolve.
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